Carbonic anhydrase inhibitors show promise in reducing tau protein buildup and neurodegeneration, paving the way for new treatments in neurodegenerative diseases. In a recent study published in ...

Sulthiame is an investigational, generally well-tolerated oral carbonic anhydrase inhibitor that is designed to restore breathing stability which is often a contributing mechanism in people with OSA.